Combining ibrutinib and checkpoint blockade improves CD8(+) T-cell function and control of chronic lymphocytic leukemia in E mu-TCL1 mice

Erstveröffentlichung
2021
Authors
Hanna, Bola S.
Yazdanparast, Haniyeh
Demerdash, Yasmin
Roessner, Philipp M.
Schulz, Ralph
et al.
Wissenschaftlicher Artikel


Published in
Haematologica ; 106 (2021), 4. - S. 968-977. - ISSN 0390-6078
Link to publication
https://dx.doi.org/10.3324/haematol.2019.238154
Institutions
UKU. Klinik für Innere Medizin III
DFG Project THU
SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187
Subject headings
[Free subject headings]: TYROSINE KINASE INHIBITOR | IN-VIVO | TUMOR-MICROENVIRONMENT | IMMUNE DYSFUNCTION | MOUSE MODEL | CLL | ITK | CAPACITY | EFFICACY | THERAPY
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record